This is the first study of its kind using Newomics breakthrough M3 emitter technologies for microflow LC-MS, and demonstrating high-throughput, high-sensitivity, and robustness for analysis of monoclonal antibodies (mAbs). The integrated workflow is applicable for a wide variety of biopharmaceutical R&D projects involving therapeutic antibodies, antibody-drug conjugates, biosimilars, and bispecific mAbs.
Read the Application Note here!
